Abstract
Clearance of vancomycin by hemodialysis has previously been reported to be negligible. We describe a child undergoing chronic hemodialysis using a hollow fiber dialyzer with cellulose acetate membrane. When the patient was treated with intravenous vancomycin for staphylococcal bacteremia, the serum vancomycin half-life was found to decrease by more than 90% during each course of hemodialysis. We conclude that, contrary to prevailing opinion, vancomycin can be rapidly cleared by hemodialysis in the small pediatric patient, and that the dosage should be adjusted accordingly.
This is a preview of subscription content, log in via an institution to check access.
References
Barcenas CG, Fuller TJ, Elms J, Cohen R, White MG (1976) Staphylococcal sepsis in patients on chronic hemodialysis regimens. Arch Intern Med 136: 1131–1134
Cook FV, Farrar WE Jr (1978) Vancomycin revisited. Ann Intern Med 88: 813–818
Lindholm DD, Murray JS (1966) Persistence of vancomycin in the blood during renal failure and its treatment by hemodialysis. N Engl J Med 274: 1047–1051
Cunha BA, Quintiliani R, Deglin JM, Izard MW, Nightingale CH (1981) Pharmacokinetics of vancomycin in anuria. Rev Infect Dis 3: S269-S272
Masur H, Francioli P, Ruddy M, Murray HW (1983) Vancomycin serum levels and toxicity in chronic hemodialysis patients withStaphylococcus aureus bacteremia. Clin Nephrol 20: 85–88
Westervelt F, Bastani B, Cummings R (1986) Comparative clearances of vancomycin in vivo by 3 different hemodialysis membranes (Cuprophan, cellulose acetate, and polyacrilonitrile [PAN]. Kidney Int 29: 228
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schoumacher, R., Chevalier, R.L., Gomez, R.A. et al. Enhanced clearance of vancomycin by hemodialysis in a child. Pediatr Nephrol 3, 83–85 (1989). https://doi.org/10.1007/BF00859632
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00859632